Comparative Nonclinical Assessments of the Proposed Biosimilar PF-05280014 and Trastuzumab (Herceptin®)
Crossref DOI link: https://doi.org/10.1007/s40259-014-0103-4
Published Online: 2014-07-08
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hurst, Susan
Ryan, Anne M.
Ng, Chee-Keng
McNally, James M.
Lorello, Leslie G.
Finch, Gregory L.
Leach, Michael W.
Ploch, Stephen A.
Fohey, Josh A.
Smolarek, Teresa A.
License valid from 2014-07-08